Table 2.
Cytokine levels (pg/ml) in HS patients and healthy subjects.
| Parameters | Controls (N 39) | HS patients (N 30) | P | |
|---|---|---|---|---|
| Sex N (%) | F | 17 (44%) | 19 (63%) | 0.10 |
| M | 22 (56%) | 11 (37%) | ||
| Age, mean (±SD) | 33.8 (6.8) | 29.6 (13.5) | 0.096 | |
| BMI, mean (±SD) | 25.5 (3.7) | 26.6 (3.8) | 0.23 | |
| IL-1β, mean (±SD) | 2.0 (0.5) | 2.3 (0.5) | 0.014 | |
| IL-12, mean (±SD) | 11.3 (1.3) | 13.5 (3.9) | 0.002 | |
| IL-13, mean (±SD) | 5.5 (1.1) | 8.4 (4.1) | <0.001 | |
| IL-15, mean (±SD) | 347.2 (25.0) | 390.3 (38.4) | <0.001 | |
| IL-17, mean (±SD) | 25.0 (3.9) | 27.2 (5.2) | 0.048 | |
| GM-CSF, mean (±SD)) | 12.8 (0.7) | 14.5 (1.5) | <0.001 | |
| IFNγ, mean (±SD) | 13.3 (3.1) | 18.6 (4.7) | <0.001 | |
| MCP-1 (MCAF), mean (±SD) | 36.9 (15.0) | 56.1 (31.7) | 0.001 | |
| RANTES, median (IQR) | 6833.4 (5469.2, 8214.1) | 45145.1 (20829.6, 93670.0) | <0.001 | |
| PDGF-BB, median (IQR) | 1638.5 (1180.5, 1991.2) | 2306.6 (1701.6, 3208.0) | <0.001 | |
| IL-1ra, median (IQR) | 371.5 (333.0, 446.4) | 333.0 (257.0, 400.0) | 0.036 | |
| IL-5, median (IQR) | 52.3 (49.0, 55.5) | 58.5 (52.3, 67.1) | 0.002 | |
| IL-6, median (IQR) | 7.6 (7.0, 8.1) | 9.0 (7.8, 10.2) | <0.001 | |
| VEGF, mean (SD) | 417.6 (40.2) | 452.3 (52.7) | 0.003 | |
BMI = body mass index; HS = hidradenitis suppurativa; SD = standard deviation. Acronym list: IL (interleukin); Granulocyte-Macrophage Colony-Stimulating (GM-CSF); Interferon (INF); Monocytes Chemoattractant Protein(MCP); Platelet-Derived Growth Factor-BB (PDGF-BB); Vascular Endothelial Growth Factor (VEGF).